Skip to main content
. 2022 Jun 12;19(12):7198. doi: 10.3390/ijerph19127198

Table 4.

Comorbidities associated with substance use among people living with HIV.

Non-Infectious Infectious
Cardiovascular Bacterial
    High blood pressure [194,218] Pneumonia [197,219]
    Strokes, cardiovascular accidents [194,197] Tuberculosis [190,195,220]
Endocrine Treatment default [190,221]
    Diabetes mellitus [194] Treatment delay [192]
    Early natural menopause [222] Treatment failure [195]
Nutritional Loss to follow-up [195]
    Malnutrition [200] Mortality [221]
    Low body mass index [200] Multi drug resistance [221]
    Low skeletal muscle mass index [200] Chlamydia trachomatis urethritis [223]
    Osteopenia and osteoporosis [188] Syphilis [22]
    Gastrointestinal symptoms [185] Viral
Malignancies HTLV-1/2 [224,225]
    Lung cancer [197] Hepatitis B [186,226]
    Kaposi’s sarcoma [227] Hepatitis C [215,216,228,229,230,231,232]
    Anal intraepithelial neoplasia [187] Hepatitis E [198]
    Cervical cancer and HPV [209,233,234] Epstein-Barr virus [39,235]
Psychiatric Fungal
    Depression [14,19,24,112,126,194,197] Oral candidiasis [235,236]
    Suicidal ideation [31,60]
    Anxiety [189]
    Bipolar disease [237]
    Manic symptoms [183]